Goodwill and Intangible Assets, Net

6 Months Ended

Sep. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Changes in the carrying amount of goodwill were as follows:



(In millions)	Distribution Solutions			Technology Solutions			Total
Balance, March 31, 2016	$	7,987		$	1,799		$	9,786
Goodwill acquired	1,597			22			1,619
Impairment	—			(290		)	(290		)
Amount reclassified to assets held for sale	—			(1,075		)	(1,075		)
Acquisition accounting, transfers and other adjustments	(143		)	—			(143		)
Foreign currency translation adjustments, net	(202		)	(2		)	(204		)
Balance, September 30, 2016	$	9,239		$	454		$	9,693

As of September 30, 2016 and March 31, 2016, the accumulated goodwill impairment losses were $290 million and $36 million primarily in our Technology Solutions segment. Refer to Financial Notes 2 and 3, “Proposed Healthcare Technology Net Asset Exchange” and “Goodwill Impairment,” for more information on goodwill reclassified to assets held for sale and the impairment charge recorded during the second quarter of 2017.

Information regarding intangible assets is as follows:



	September 30, 2016								March 31, 2016
(Dollars in millions)	Weighted Average Remaining Amortization Period (years)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Customer relationships	8	$	2,435	$	(1,182	)	$	1,253	$	2,652	$	(1,324	)	$	1,328
Service agreements	14	955		(287		)	668		959		(269		)	690
Pharmacy licenses	24	836		(134		)	702		857		(121		)	736
Trademarks and trade names	14	475		(99		)	376		314		(96		)	218
Technology	1	66		(62		)	4		195		(182		)	13
Other	5	203		(145		)	58		163		(127		)	36
Total		$	4,970	$	(1,909	)	$	3,061	$	5,140	$	(2,119	)	$	3,021

Amortization expense of intangible assets was $115 million and $230 million for the quarter and six months ended September 30, 2016 and $109 million and $221 million for the quarter and six months ended September 30, 2015. Estimated annual amortization expense of these assets is as follows: $181 million, $369 million, $350 million, $325 million and $298 million for the remainder of 2017 and each of the succeeding years through 2021 and $1,538 million thereafter. All intangible assets were subject to amortization as of September 30, 2016 and March 31, 2016.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details